# Phentermine/Topiramate for Uric Acid Stones

> **NCT04621929** · PHASE3 · COMPLETED · sponsor: **University of Florida** · enrollment: 19 (actual)

## Conditions studied

- Obesity
- Uric Acid Stones
- Type 2 Diabetes Mellitus in Obese
- Pre-Diabetes

## Interventions

- **DRUG:** Phentermine / Topiramate Oral Product
- **COMBINATION_PRODUCT:** Citrate Salts, Allopurinol, Diet

## Key facts

- **NCT ID:** NCT04621929
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-31
- **Primary completion:** 2024-11-14
- **Final completion:** 2024-11-14
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04621929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04621929, "Phentermine/Topiramate for Uric Acid Stones". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04621929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*